摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-dimethylbutyl 4-methylbenzenesulfonate | 68880-56-8

中文名称
——
中文别名
——
英文名称
3,3-dimethylbutyl 4-methylbenzenesulfonate
英文别名
3, 4-Methylbenzenesulfonate
3,3-dimethylbutyl 4-methylbenzenesulfonate化学式
CAS
68880-56-8
化学式
C13H20O3S
mdl
——
分子量
256.366
InChiKey
XUCWOJZNDILAOI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    353.0±11.0 °C(Predicted)
  • 密度:
    1.084±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    17
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:8c8687b5e62572e29ec084cadb01643c
查看

反应信息

  • 作为反应物:
    描述:
    3,3-dimethylbutyl 4-methylbenzenesulfonatepotassium carbonate三氟乙酸 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 36.0h, 生成 5,15-bis[3',5'-di(3,3-dimethyl-1-butyloxy)phenyl]porphyrin
    参考文献:
    名称:
    Decoupling Optical and Potentiometric Band Gaps in π-Conjugated Materials
    摘要:
    Syntheses, optical spectroscopy, potentiometric studies, and electronic structural calculations are reported for two classes of conjugated (porphinato)metal oligomers that feature a meso-to-meso ethyne-bridged linkage topology. One set of these systems, bis[(5,5'-10,20-bis[3,5-bis(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]ethyne (DD), 5,15-bis[[5'-10',20'-bis[3,5-di(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]ethynyl]-10,20-bis[3,5-di(9-methoxy-1,4,7-trioxanonyl)phenyl]porphinato)zinc(II) (DDD), and 5,15-bis[[15' '-(5'-10',20'-bis[3,5-bis(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]-[(5' '-10' ',20' '-bis[3,5-di(9-methoxy-1,4,7-trioxanonyl)phenyl]porphinato)zinc(II)]ethyne]ethynyl]-10,20-bis[3,5-di(9-methoxy-1,4,7-trioxanonyl)phenyl]porphinato)zinc(II) (DDDDD), constitute highly soluble analogues of previously studied examples of this structural motif having simple 10,20-diaryl substituents, while a corresponding set of conjugated oligomers, [(5-10,20-bis[3,5-bis(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]-[(5'-15'-ethynyl-10',20'-bis[10,20-bis(heptafluoropropyl)porphinato)zinc(II)]ethyne (DA), 5,15-bis[[5'-10',20'-bis[3,5-di(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]ethynyl]-10,20-bis(heptafluoropropyl)porphinato]zinc(II) (DAD), and 5,15-bis[[15' '-(5'-10',20'-bis[3,5-bis(3,3-dimethyl-1-butyloxy)phenyl]porphinato)zinc(II)]-[(5' '-(10' ',20' '-bis(heptafluoropropyl)porphinato)zinc(II)]ethyne]ethynyl]-10,20-bis[3,5-di(9-methoxy-1,4,7-trioxanonyl)phenyl]porphinato)zinc(II) (DADAD), features alternating electron-rich and electron-poor (porphinato)zinc(II) units. Electrooptic and computational data for these species demonstrate that it is possible to engineer conjugated oligomeric structures that possess highly delocalized singlet (S1) excited states yet manifest apparent one-electron oxidation and reduction potentials (E1/20/+ and E1/2-/0 values) that are essentially invariant with respect to those elucidated for their constituent monomeric precursors.
    DOI:
    10.1021/ja0203925
  • 作为产物:
    描述:
    3,3-二甲基-1-丁酸吡啶 、 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 反应 16.0h, 生成 3,3-dimethylbutyl 4-methylbenzenesulfonate
    参考文献:
    名称:
    Lee, Sueg-Geun, Journal of the Chemical Society. Perkin transactions II, 1993, # 7, p. 1361 - 1372
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY<br/>[FR] HÉTÉROARYLAMINOSULFONAMIDES À 5 CHAÎNONS POUR LE TRAITEMENT D'ÉTATS À MÉDIATION PAR UNE ACTIVITÉ CFTR DÉFICIENTE
    申请人:GENZYME CORP
    公开号:WO2021097057A1
    公开(公告)日:2021-05-20
    The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    这项发明涉及杂环芳基化合物,其药用盐以及药物制剂。本文还描述了这些化合物的组成以及在治疗由CFTR活性不足介导的疾病和病况的方法中的使用,特别是囊性纤维化。
  • [EN] NOVEL AZAINDOLE DERIVATIVES AS SELECTIVE HISTONE DEACETYLASE (HDAC) INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME<br/>[FR] NOUVEAUX DÉRIVÉS AZAINDOLE COMME INHIBITEURS SÉLECTIFS DE L'HISTONE DÉSACÉTYLASE (HDAC) ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
    申请人:CHONG KUN DANG PHARM CORP
    公开号:WO2015087151A1
    公开(公告)日:2015-06-18
    The present invention relates to novel azaindole derivatives, and more particularly, to novel azaindole derivatives having histone deacetylase (HDAC) inhibitory activity, isomers thereof, pharmaceutically acceptable salts thereof, hydrates thereof or solvates thereof, the use thereof for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same, a method of treating disease using the pharmaceutical compositions, and methods for preparing the novel azaindole derivatives. The novel azaindole derivatives according to the present invention are selective histone deacetylase (HDAC) inhibitors, and may be used as agents for treating malignant tumor diseases, inflammatory diseases, rheumatoid arthritis, and neurodegenerative diseases.
    本发明涉及新型的吖吲哚衍生物,特别是具有组蛋白去乙酰化酶(HDAC)抑制活性的新型吖吲哚衍生物,其异构体,药用可接受的盐,水合物或溶剂化物,以及它们用于制备药物组合物的用途,包含同一的药物组合物,使用该药物组合物治疗疾病的方法,以及制备新型吖吲哚衍生物的方法。根据本发明的吖吲哚衍生物是选择性的组蛋白去乙酰化酶(HDAC)抑制剂,可用作治疗恶性肿瘤疾病,炎症性疾病,类风湿性关节炎和神经退行性疾病的治疗剂。
  • Remote Arylative Substitution of Alkenes Possessing an Acetoxy Group via β‐Acetoxy Elimination
    作者:Kazuma Muto、Takaaki Kumagai、Fumitoshi Kakiuchi、Takuya Kochi
    DOI:10.1002/anie.202111396
    日期:2021.11.8
    Palladium-catalyzed remote arylative substitution was achieved for the reaction of arylboronic acids with alkenes possessing a distant acetoxy group via nondissociative chain walking and β-acetoxy elimination.
    芳基硼酸与具有远距离乙酰氧基的烯烃通过非离解链行走和β-乙酰氧基消除反应,实现了钯催化的远程芳基化取代。
  • Neighboring group participation by sulfur involving four-membered-ring intermediates (RS-4)
    作者:Ernest L. Eliel、David E. Knox
    DOI:10.1021/ja00296a019
    日期:1985.5
    On etudie les produits de methanolyse et de trifluoroethanolyse ainsi que les vitesses de methanolyse d'un certain nombre de p-toluenesulfonates d'alkylthio-3 et d'arylthio-3 propyle substitues sur la chaine
    On etudi les produits demethylyse et de trifluoroethanolyse ainsi que les vitesses demethylyse d'un some nombre de p-甲苯磺酸 d'alkylthio-3 et de d'arylthio-3 propyle substitues
  • Yi, Guoliang; Bradshaw, Jerald S.; Krakowiak, Krzysztof E, Journal of Heterocyclic Chemistry, 1993, vol. 30, # 5, p. 1173 - 1176
    作者:Yi, Guoliang、Bradshaw, Jerald S.、Krakowiak, Krzysztof E、Huang, Mingxian、Lee, Milton L.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐